A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway

Oncotarget

Volumn 5, Issue 13, 2014, Pages 4683-4693

  Meng, Jin ^a   Li, Ping ^a   Zhang, Qing ^b,c   Yang, Zhangru ^a   Fu, Shen ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c Shanghai Proton and Heavy Ion Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CELL; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PHENOTYPE; PREDICTION; RADIOSENSITIVITY; SURVIVAL TIME; ADOLESCENT; AGED; BRAIN NEOPLASMS; CHILD; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; OUTCOME ASSESSMENT; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RADIATION RESPONSE; STATISTICS AND NUMERICAL DATA; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

TRANSCRIPTOME; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CLUSTER ANALYSIS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIATION TOLERANCE; SURVIVAL ANALYSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84904989294     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2088     Document Type: Article

References (50)

1. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-oncology. 2013; 15 Suppl 2:ii1-56.
2. Bralten LB and French PJ. Genetic alterations in glioma. Cancers. 2011; 3(1):1129-1140.
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica. 2007; 114(2):97-109.
4. Ohgaki H and Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of neuropathology and experimental neurology. 2005; 64(6):479-489.
5. Pedersen CL and Romner B. Current treatment of low grade astrocytoma: a review. Clinical neurology and neurosurgery. 2013; 115(1):1-8.
6. Omuro A and DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA: the journal of the American Medical Association. 2013; 310(17):1842-1850.
7. Liauw SL, Connell PP and Weichselbaum RR. New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Science translational medicine. 2013; 5(173):173sr172.
8. Ke C, Tran K, Chen Y, Di Donato AT, Yu L, Hu Y, Linskey ME, Wang PH, Limoli CL and Zhou YH. Linking differential radiation responses to glioma heterogeneity. Oncotarget. 2014.
9. Asuthkar S, Velpula KK, Chetty C, Gorantla B and Rao JS. Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity. Oncotarget. 2012; 3(11):1439-1454.
10. Hirst DG and Robson T. Molecular biology: the key to personalised treatment in radiation oncology? The British journal of radiology. 2010; 83(993):723-728.
11. Dalton WS and Friend SH. Cancer biomarkers-an invitation to the table. Science. 2006; 312(5777):1165-1168.
12. Begg AC. Predicting response to radiotherapy: evolutions and revolutions. International journal of radiation biology. 2009; 85(10):825-836.
13. Salendo J, Spitzner M, Kramer F, Zhang X, Jo P, WolffHA, Kitz J, Kaulfuss S, Beissbarth T, Dobbelstein M, Ghadimi M, Grade M and Gaedcke J. Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a,-224,-132 and let7g. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2013; 108(3):451-457.
14. Spitzner M, Emons G, Kramer F, Gaedcke J, Rave-Frank M, Scharf JG, Burfeind P, Becker H, Beissbarth T, Ghadimi BM, Ried T and Grade M. A gene expression signature for chemoradiosensitivity of colorectal cancer cells. International journal of radiation oncology, biology, physics. 2010; 78(4):1184-1192.
15. Hall JS, Iype R, Senra J, Taylor J, Armenoult L, Oguejiofor K, Li Y, Stratford I, Stern PL, O'Connor MJ, Miller CJ and West CM. Investigation of radiosensitivity gene signatures in cancer cell lines. PloS one. 2014; 9(1):e86329.
16. Pramana J, Van den Brekel MW, van Velthuysen ML, Wessels LF, Nuyten DS, Hofland I, Atsma D, Pimentel N, Hoebers FJ, Rasch CR and Begg AC. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. International journal of radiation oncology, biology, physics. 2007; 69(5):1544-1552.
17. Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer cell. 2013; 24(3):331-346.
18. Snijders AM, Marchetti F, Bhatnagar S, Duru N, Han J, Hu Z, Mao JH, Gray JW and Wyrobek AJ. Genetic differences in transcript responses to low-dose ionizing radiation identify tissue functions associated with breast cancer susceptibility. PloS one. 2012; 7(10):e45394.
19. Imadome K, Iwakawa M, Nakawatari M, Fujita H, Kato S, Ohno T, Nakamura E, Ohkubo Y, Tamaki T, Kiyohara H and Imai T. Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity. Cancer biology & therapy. 2010; 10(10):1019-1026.
20. Eschrich SA, Pramana J, Zhang H, Zhao H, Boulware D, Lee JH, Bloom G, Rocha-Lima C, Kelley S, Calvin DP, Yeatman TJ, Begg AC and Torres-Roca JF. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. International journal of radiation oncology, biology, physics. 2009; 75(2):489-496.
21. Eschrich S, Zhang H, Zhao H, Boulware D, Lee JH, Bloom G and Torres-Roca JF. Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. International journal of radiation oncology, biology, physics. 2009; 75(2):497-505.
22. Eschrich SA, Fulp WJ, Pawitan Y, Foekens JA, Smid M, Martens JW, Echevarria M, Kamath V, Lee JH, Harris EE, Bergh J and Torres-Roca JF. Validation of a radiosensitivity molecular signature in breast cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2012; 18(18):5134-5143.
23. Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DS, Baker SW, Khodarev N, Su AW, Shaikh AY, Roach P, Kreike B, Roizman B, Bergh J, Pawitan Y, van de Vijver MJ and Minn AJ. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(47):18490-18495.
24. Kim HS, Kim SC, Kim SJ, Park CH, Jeung HC, Kim YB, Ahn JB, Chung HC and Rha SY. Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells. BMC genomics. 2012; 13:348.
25. Kuehn H, Liberzon A, Reich M and Mesirov JP. Using GenePattern for gene expression analysis. Current protocols in bioinformatics/editoral board, Andreas D Baxevanis [et al]. 2008; Chapter 7:Unit 7 12.
26. Escriva M, Peiro S, Herranz N, Villagrasa P, Dave N, Montserrat-Sentis B, Murray SA, Franci C, Gridley T, Virtanen I and Garcia de Herreros A. Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Molecular and cellular biology. 2008; 28(5):1528-1540.
27. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY and Bapat SA. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem cells. 2009; 27(9):2059-2068.
28. Chang L, Graham PH, Hao J, Bucci J, Cozzi PJ, Kearsley JH and Li Y. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy. Cancer metastasis reviews. 2014.
29. Chibon F. Cancer gene expression signatures-the rise and fall? European journal of cancer. 2013; 49(8):2000-2009.
30. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415(6871):530-536.
31. Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, Floore A, Glas AM, Bogaerts J, Cardoso F, Piccart-Gebhart MJ, Rutgers ET, Van't Veer LJ and Consortium T. The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast cancer research and treatment. 2009; 116(2):295-302.
32. Bueno-de-Mesquita JM, Linn SC, Keijzer R, Wesseling J, Nuyten DS, van Krimpen C, Meijers C, de Graaf PW, Bos MM, Hart AA, Rutgers EJ, Peterse JL, Halfwerk H, de Groot R, Pronk A, Floore AN, et al. Validation of 70-gene prognosis signature in node-negative breast cancer. Breast cancer research and treatment. 2009; 117(3):483-495.
33. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, et al. A gene-expression signature as a predictor of survival in breast cancer. The New England journal of medicine. 2002; 347(25):1999-2009.
34. Straver ME, Glas AM, Hannemann J, Wesseling J, van de Vijver MJ, Rutgers EJ, Vrancken Peeters MJ, van Tinteren H, Van't Veer LJ and Rodenhuis S. The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer. Breast cancer research and treatment. 2010; 119(3):551-558.
35. Shukla S, Pia Patric IR, Thinagararjan S, Srinivasan S, Mondal B, Hegde AS, Chandramouli BA, Santosh V, Arivazhagan A and Somasundaram K. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-kappaB nexus. Cancer research. 2013; 73(22):6563-6573.
36. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS and Nelson SF. Gene expression profiling of gliomas strongly predicts survival. Cancer research. 2004; 64(18):6503-6510.
37. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR and Louis DN. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer research. 2003; 63(7):1602-1607.
38. Bauman G, Fisher B, Watling C, Cairncross JG and Macdonald D. Adult supratentorial low-grade glioma: long-term experience at a single institution. International journal of radiation oncology, biology, physics. 2009; 75(5):1401-1407.
39. Chaudhry NS, Shah AH, Ferraro N, Snelling BM, Bregy A, Madhavan K and Komotar RJ. Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century. Cancer investigation. 2013; 31(5):287-308.
40. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G and German Glioma N. Long-term survival with glioblastoma multiforme. Brain: a journal of neurology. 2007; 130(Pt 10):2596-2606.
41. Ducray F, Idbaih A, Wang XW, Cheneau C, Labussiere M and Sanson M. Predictive and prognostic factors for gliomas. Expert review of anticancer therapy. 2011; 11(5):781-789.
42. Nobusawa S, Watanabe T, Kleihues P and Ohgaki H. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009; 15(19):6002-6007.
43. Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, Schramm J, Westphal M, Schackert G, Simon M, Tonn JC, Heese O, Krex D, Nikkhah G, Pietsch T, Wiestler O, Reifenberger G, et al. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2009; 27(34):5743-5750.
44. Desgrosellier JS and Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nature reviews Cancer. 2010; 10(1):9-22.
45. Tiwari N, Gheldof A, Tatari M and Christofori G. EMT as the ultimate survival mechanism of cancer cells. Seminars in cancer biology. 2012; 22(3):194-207.
46. Zhou YC, Liu JY, Li J, Zhang J, Xu YQ, Zhang HW, Qiu LB, Ding GR, Su XM, Mei S and Guo GZ. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. International journal of radiation oncology, biology, physics. 2011; 81(5):1530-1537.
47. Theys J, Jutten B, Habets R, Paesmans K, Groot AJ, Lambin P, Wouters BG, Lammering G and Vooijs M. E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2011; 99(3):392-397.
48. Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer research. 2009; 69(23):9065-9072.
49. Cancer Genome Atlas Research N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008; 455(7216):1061-1068.
50. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES and Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(43):15545-15550.